Adhera Therapeutics, Inc. (ATRX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Baton Rouge, LA, 美国. 现任CEO为 Andrew Albert Kucharchuk.
ATRX 拥有 IPO日期为 1993-12-07, 2 名全职员工, 在 Other OTC, 市值为 $722.00.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
